Nu Skin Enterprises Inc. (NUS) Misses Q2 EPS by 14c; Warns for Q3

Go back to Nu Skin Enterprises Inc. (NUS) Misses Q2 EPS by 14c; Warns for Q3

JPMorgan Downgrades Nu Skin Enterprises (NUS) to Neutral

August 7, 2014 6:47 AM EDT

JPMorgan downgraded Nu Skin Enterprises (NYSE: NUS) from Overweight to Neutral with a price target of $50.00 (from $100.00).

For an analyst ratings summary and ratings history on Nu Skin Enterprises click here. For more ratings news on Nu Skin Enterprises click here.

Shares of Nu Skin Enterprises closed at $46.52 yesterday.

... More

Nu Skin Enterprises (NUS) Slammed on Q2 'Miss', Q3 Warning

August 6, 2014 8:15 AM EDT

Nu Skin Enterprises (NYSE: NUS) is down a quick 15% on disappointing Q2 results and outlook. Peers are also on watch: Herbalife Ltd. (NYSE: HLF) (-1.7%) and USANA Health Sciences Inc. (NYSE: USNA).

... More

Nu Skin Enterprises (NUS) Restates Q1 Financials Following Audit Committee Determination

August 6, 2014 7:40 AM EDT

On August 5, 2014 the Audit Committee (the "Committee") of Nu Skin Enterprises (NYSE: NUS) determined to restate the Company's consolidated financial statements for the quarter ended March 31, 2014 to correct the accounting related to (i) hyper-inflationary adjustments with respect to operations in Venezuela, and (ii) tax rebates related to the Company's new China headquarters. Based on discussions with its independent registered public accounting firm, PricewaterhouseCoopers LLP, the Committee has determined that hyper-inflationary adjustments should have been recorded as charges to Other Income (Expense) rather than as adjustments to Accumulated Other Comprehensive Loss in the Stockholders'... More